A conversation with Gabor Bethlendy, serial entrepreneur.

A conversation with Jo Bhakdi, founder and CEO of Quantgene. The Serenity 'super checkup' discussed in the podcast is available at https://getserenity.life/

Jo elaborates on his comment that "we'll see some very crazy things happen in the next five years":

My comment in regards to the next 5 years refers to the revolution in generative AI. Generative AI in the form of large language and transformer models are now dramatically disrupting our medical and genomic intelligence capabilities. This leads to lower costs, but also much greater capabilities in connecting data points into clinical knowledge. If we combine this revolution with advances in sequencing technology and cost structure, systems like Serenity will not only be able to detect all major diseases (major in the sense of leading causes of death) at early stages - effectively rendering them much less dangerous - but also doing so at very affordable costs. Today, universal annual screenings like Serenity can already dramatically reduce your risk of death by cancer, heart disease, stroke, metabolic and neurodegenerative conditions - but these trajectories will drive the price for systems like Serenity down from around $400  / month to $99 and below. This will be - by far! - the greatest advancement in modern medicine since its invention in the late 1800s, with the potential to save a million lives every single year just in the US. We are living in truly transformative times for medicine.

A conversation with Haruna Cofer, a Senior Applications Engineer at HPE.

A conversation with Krist Sokoli about how genomics can benefit from blockchain technology.

A conversation with Mike Lelivelt, Illumina’s VP of Product.